Jaguar Health, Inc. (JAGX) › Cost of RevenueJaguar Health, Inc. (JAGX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2015: $123.5K2016: $52.0K2017: $880.4K2018: $2.77M2019: $3.82M2020: $3.28M2021: $2.33M2022: $2.02M2023: $2.04M2024: $1.96M2025: $3.77M$3.77M2015Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$3.77M+93.0%2024$1.96M-4.0%2023$2.04M+0.9%2022$2.02M-13.5%2021$2.33M-28.9%2020$3.28M-14.0%2019$3.82M+38.0%2018$2.77M+214.1%2017$880.4K+1594.2%2016$52.0K-57.9%2015$123.5K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share